Skip to main content
Tchaikapharma High Quality Medicines AD logo

Tchaikapharma High Quality Medicines AD — Investor Relations & Filings

Ticker · THQM ISIN · BG1100008074 LEI · 5299003VDHTK75D1JE38 BSOBGN Manufacturing
Open in API
Filings indexed 13 across all filing types
Latest filing 2024-04-15 Audit Report / Informat…
Country BG Bulgaria
Listing BSOBGN THQM

About Tchaikapharma High Quality Medicines AD

https://tchaikapharma.com/

Tchaikapharma High Quality Medicines AD is a pharmaceutical company that develops and manufactures generic and in-licensed medicinal products. The company focuses on producing affordable, contemporary pharmaceuticals with a proven cost-effectiveness ratio to combat socially significant diseases. Its product portfolio targets a range of therapeutic areas, with a significant focus on cardiovascular conditions, including arterial hypertension, angina pectoris, and thrombosis. Other areas of specialization include treatments for cerebrovascular disease, Parkinson's disease, and metabolic syndrome, as well as anesthetics and anti-inflammatory drugs. The company is also a manufacturer of complex generics, such as polypills (fixed-dose combination medications).

Recent filings

Filing Released Lang Actions
5299003VDHTK75D1JE38-20231231-BG-CON_CALCULATION-RES.html
Audit Report / Information Classification · 95% confidence The document text consists of structured data tables containing financial line items such as 'Comprehensive income', 'Revenue', 'Assets', 'Equity', and 'Liabilities', along with comparative data for 2022 and 2023. It explicitly mentions 'Calculation validation report' and contains XBRL processing engine information and links to roles like 'konsolidiranotchetzavseobhvatnijadohod' (Consolidated Statement of Comprehensive Income) and 'otchetzafinansovotosstojanie' (Statement of Financial Position). This structure strongly indicates the presence of detailed financial statements, likely extracted from an annual or interim report, but presented in a raw data/validation format. Since it covers a full year (2023-12-31 context) and includes comprehensive financial details, it is most closely related to the full financial reporting package. However, the format is highly technical (XBRL validation output) rather than the narrative 10-K or the standard Interim Report (IR). Given the comprehensive nature covering a full fiscal year and containing both Income Statement and Balance Sheet data points, it is most likely derived from the Annual Report (10-K) data, or if it's a standalone set of audited statements, it falls under Audit Report/Information (AR). Since the content is purely structured financial data validation, and not the narrative 10-K, 'AR' (Audit Report / Information) is a better fit than 10-K, as 10-K implies the full regulatory filing document. If this were a standalone set of audited statements, AR is appropriate. If it's just the data tables extracted from a 10-K, it's still fundamentally financial statement data. Given the presence of full year data and multiple statements (Income, Position, Cash Flow links), I lean towards the comprehensive financial reporting category. Since it's not the narrative 10-K, and it contains detailed financial results validation, AR is the most suitable classification among the options for detailed financial statements. FY 2023
2024-04-15 English
609557-7TH_2023 CONS_BG_signed.xls
Regulatory Filings Classification · 19% confidence
2024-04-15 Bulgarian
609559-7TH_2023 CONS_EN_signed.xls
Regulatory Filings Classification · 19% confidence
2024-04-15 Bulgarian
609558-5299003VDHTK75D1JE38-20231231-EN-CON.zip
Management Reports Classification · 95% confidence The document is titled 'ANNUAL MANAGEMENT REPORT for 2023' and contains detailed information about the company, including history, corporate governance, board of directors, shareholding structure, economic activity, research and development, major trading partners, employee statistics, and financial data for the year ending 31.12.2023. It includes consolidated financial statements and detailed management commentary on company operations and governance. The length is substantial (15,000 characters) and the content is comprehensive, indicating it is a full report rather than a brief announcement or certification. The document fits the description of a Management Report (MDA), which provides management's detailed explanation of financial results, business trends, and outlook. It is not a full Annual Report (10-K) as it lacks full audited financial statements and notes, nor is it an Interim Report (IR) or Earnings Release (ER). It is also not a Proxy Statement, Governance Information, or other categories. Therefore, the best classification is Management Reports (MDA). FY 2023
2024-04-15 Bulgarian
608037-SPRAVKA_1_IND_GFO_6M.xls
Interim / Quarterly Report Classification · 19% confidence
2024-03-26 Bulgarian
5299003VDHTK75D1JE38-20231231-BG-SEP.xhtml
Management Reports Classification · 99% confidence The document text contains extensive details typical of a comprehensive annual review, including company history, management structure, business activities, R&D updates, employee statistics, major counterparties, corporate governance compliance (mentioning the Corporate Governance Code and remuneration policy), and financial highlights for the year 2023. Key phrases like 'ГОДИШЕН ДОКЛАД ЗА ДЕЙНОСТТА за 2023г.' (Annual Report on Activities for 2023), 'Audit report 2023', and detailed year-end information strongly indicate this is the company's primary annual filing. Although it is in Bulgarian and not explicitly labeled '10-K', its content scope matches the definition of an Annual Report (AR/10-K). Given the comprehensive nature and the explicit mention of the 'Annual Report' for the full fiscal year 2023, the most appropriate classification is Annual Report (10-K), as it covers the full scope of yearly performance and activities.
2024-03-26 Bulgarian

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.